Keywords: amgen, unveils, promising, pipeline, investors, remain, uncertain

Amgen unveils a promising R&D pipeline but investors remain uncertain

Article | 05 April 2004

Print This

The USA's Amgen presented its full R&D pipeline of potential drugs last week, but its shares slumped as the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in